Northwest Biotherapeutics, Inc. Stock
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
OTC Markets
05:59:53 05/06/26 am AEST
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+19.70% | -10.38% |
| Market Cap | 306M 263M 247M 225M 425M 29.2B 426M 2.93B 1.14B 14.74B 1.15B 1.12B 48.88B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 402M 346M 324M 296M 558M 38.39B 560M 3.85B 1.5B 19.38B 1.51B 1.48B 64.25B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 11.1x |
| Free-Float |
95.22% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +19.70% | ||
| Current month | +25.00% | ||
| 1 month | +18.09% | ||
| 3 months | -3.30% | ||
| 6 months | -9.25% | ||
| Current year | -10.38% |
| 1 week | 0.17 |  | 0.22 |
| 1 month | 0.16 | | 0.22 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.34 |
| 3 years | 0.14 | | 1.09 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Alton Boynton
CEO | Chief Executive Officer | 82 | 01/06/2007 |
Linda Powers
CEO | Chief Executive Officer | 71 | 08/06/2011 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 01/01/2000 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 01/01/1998 |
Linda Powers
CHM | Chairman | 71 | 17/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 01/04/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/8/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 9/8/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 8/8/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +19.70% | -21.88% | -61.02% | 306M | |
| -1.59% | -6.25% | +64.99% | +99.09% | 70.64B | |
| -1.34% | +1.13% | +47.33% | +90.79% | 66.11B | |
| -8.37% | -7.95% | -0.91% | -13.21% | 27.98B | |
| -2.35% | -5.23% | -11.89% | +442.77% | 26.51B | |
| +0.30% | +2.03% | +59.48% | +14.21% | 26.44B | |
| -0.96% | +12.36% | +280.38% | +439.54% | 20.4B | |
| -0.51% | +0.70% | +35.85% | -16.21% | 20.17B | |
| -1.91% | -3.47% | +11.03% | +508.52% | 15.99B | |
| -1.47% | +1.42% | +41.39% | +147.61% | 13.69B | |
| Average | -1.77% | +1.00% | +50.58% | +165.21% | 28.82B | |
| Weighted average by Cap. | -1.98% | +1.22% | +55.97% | +150.99% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 33.55M 31.46M 28.71M 54.09M 3.72B 54.27M 373M 146M 1.88B 146M 143M 6.23B |
| Net income | - | - |
| Net Debt | 96.08M 82.79M 77.63M 70.86M 133M 9.18B 134M 921M 359M 4.64B 361M 353M 15.37B | 125M 108M 101M 92.14M 174M 11.94B 174M 1.2B 467M 6.03B 469M 459M 19.99B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | USD 0.1896 | +5.84% | 10,430,794 |
| 27/08/26 | USD 0.1791 | +3.55% | 2,417,558 |
| 26/08/26 | USD 0.1730 | -0.52% | 1,262,376 |
| 25/08/26 | USD 0.1739 | +0.82% | 1,936,134 |
| 24/08/26 | USD 0.1725 | +1.70% | 5,231,098 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1791USD
Average target price
1.000USD
Spread / Average Target
+458.22%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
